Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis
- 24 April 2023
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (2) , 254-261
Abstract
Background and Objectives: Disparities in pancreas cancer care are multifactorial, but factors are often examined in isolation. Research that integrates these factors in a single conceptual framework is lacking. We use latent class analysis (LCA) to evaluate the association between intersectionality and patterns of care and survival in patients with resectable pancreas cancer.Methods: LCA was used to identify demographic profiles in resectable pancreas cancer (n = 140 344) diagnosed from 2004 to 2019 in the National Cancer Database (NCDB). LCA‐derived patient profiles were used to identify differences in receipt of minimum expected treatment (definitive surgery), optimal treatment (definitive surgery and chemotherapy), time to treatment, and overall survival.Results: Minimum expected treatment (hazard ratio [HR] 0.69, 95% confidence interval [CI]: 0.65, 0.75) and optimal treatment (HR 0.58, 95% CI: 0.55, 0.62) were associated with improved overall survival. Seven latent classes were identified based on age, race/ethnicity, and socioeconomic status (SES) attributes (zip code‐linked education and income, insurance, geography). Compared to the referent group (≥65 years + White + med/high SES), the ≥65 years + Black profile had the longest time‐to‐treatment (24 days vs. 28 days) and lowest odds of receiving minimum (odds ratio [OR] 0.67, 95% CI: 0.64, 0.71) or optimal treatment (OR 0.76, 95% CI: 0.72, 0.81). The Hispanic patient profile had the lowest median overall survival—55.3 months versus 67.5 months.Conclusions: Accounting for intersectionality in the NCDB resectable pancreatic cancer patient cohort identifies subgroups at higher risk for inequities in care. LCA demonstrates that older Black patients and Hispanic patients are at particular risk for being underserved and should be prioritiz for directed interventions.Keywords
This publication has 33 references indexed in Scilit:
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- Trends in Racial Disparities in Pancreatic Cancer SurgeryJournal of Gastrointestinal Surgery, 2013
- Disparities in Pancreas Cancer CareAnnals of Surgical Oncology, 2013
- Racial Disparities in Surgical Resection and Survival among Elderly Patients with Poor Prognosis CancerJournal of the American College of Surgeons, 2013
- Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysisJournal of Cancer Research and Clinical Oncology, 2012
- Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancerCancer, 2010
- Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?Cancer, 2009
- Racial Differences in Cancer Specialist Consultation, Treatment, and Outcomes for Locoregional Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Pancreatic resectionCancer, 2009
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007